AVHEC17 Key Research Summary Conference Report
This report captures key learnings from the inaugural Australasian Viral Hepatitis Elimination Conference (AVHEC 2017). The conference took place on 10-11 August 2017 in Cairns, Queensland, with over 300 delegates including health professionals, policy makers, researchers, community organisations and people living with viral hepatitis committed to eliminating hepatitis B and C as a major public health threat. The conference was organised by the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) with a program highlighting latest scientific developments, as well as real world implementation of best practice care. The meeting offered opportunities for structured dialogue assessing where we are and the work still to be done in the Australasian response to viral hepatitis. Download a PDF version of this report here: http://bit.ly/AVHEC17ReportPDF Visit the conference website www.avhec.com.au
This report captures key learnings from the inaugural Australasian Viral Hepatitis Elimination Conference (AVHEC 2017). The conference took place on 10-11 August 2017 in Cairns, Queensland, with over 300 delegates including health professionals, policy makers, researchers, community organisations and people living with viral hepatitis committed to eliminating hepatitis B and C as a major public health threat.
The conference was organised by the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) with a program highlighting latest scientific developments, as well as real world implementation of best practice care. The meeting offered opportunities for structured dialogue assessing where we are and the work still to be done in the Australasian response to viral hepatitis. Download a PDF version of this report here: http://bit.ly/AVHEC17ReportPDF
Visit the conference website www.avhec.com.au
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
These presentation slides provide latest information on:<br />
Patterns of DAA treatment, including prescriber type<br />
HCV treatment among sub-populations: cirrhosis and PWID<br />
HCV elimination modelling<br />
DAA treatment outcomes: REACH-C study<br />
Strategies to continue DAA uptake<br />
The REACH-C Study: The REACH-C report monitors the<br />
real-world efficacy of antiviral therapy in chronic hepatitis C<br />
patients from a representative selection of Australian<br />
clinics. It provides a detailed breakdown of who is receiving<br />
treatment by gender, age, jurisdiction; who is prescribing<br />
and the regiments patients are receiving.<br />
<strong>Key</strong> finding: DAA prescription from GPs increased 8% to<br />
31% from March - Dec 2016.<br />
Where is New Zealand in the race to eliminate Hepatitis C?<br />
Watch the presentation by<br />
Professor Ed Gane, Chair of<br />
the Ministry of Health<br />
Hepatitis C Implementation<br />
Committee:<br />
vimeo.com/230540433<br />
Download his<br />
presentation slides<br />
7
Change language